The medical device CRO market is estimated to be worth USD 15.7 billion in 2030, predicts Roots Analysis

Advances in the medical device industry have led to a substantial increase in developmental complexity, clinical trial conduct, and stringency of regulatory review, causing sponsors to rely on the technical and regulatory affairs management expertise of CROs

Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CRO Market (2nd Edition), 2020-2030”.

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

The report features an extensive study of the current market landscape and future opportunities of contract research service providers focused on medical devices. The study also features an in-depth analysis, highlighting the capabilities of the various stakeholders engaged in this domain, across different regions of the globe. In addition to other elements, the study includes:
A detailed review of the overall landscape of medical device CROs.
An elaborate discussion on the various guidelines established by major regulatory bodies for medical device approval across North America, Europe, and Asia-Pacific and rest of the world.
Elaborate profiles of key players that specialize in offering services for both clinical and preclinical stage development of medical devices.
An analysis highlighting the key performance indicators used by sponsor companies to evaluate service providers engaged in this domain
A competitive benchmarking, highlighting the key focus areas of small, mid-sized and large companies, comparing their existing capabilities within and beyond their respective peer groups.
A detailed brand positioning analysis of leading industry players (shortlisted on the basis of strength of service portfolio).
A detailed geographical clinical trial analysis of ongoing and planned studies related to medical devices.
A detailed analysis of the mergers and acquisitions that have taken place in this domain during the period 2015-2020.
A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing contract research services to medical device developers.
A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution.
An elaborate discussion on the future opportunities / trends for the medical device outsourcing market that are likely to influence the growth of this domain over the coming years.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Phase of Development
Clinical
Preclinical

Types of Preclinical Services Offered
Biocompatibility testing
Sterility and microbiology testing
Material characterization and analytical services
Others

Types of Clinical Services Offered
Clinical trial management
Data management
Regulatory affairs management
Consulting
Others

Device Class
Class I medical devices
Class II medical devices
Class III medical devices

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

Target Therapeutic Area
CNS disorders
Cardiovascular disorders
Oncological disorders
Bone disorders
Respiratory disorders
Pain management disorders
Ophthalmic disorders
Psychological disorders
Metabolic disorders
Others

Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World

Transcripts of interviews held with the following senior level representatives of stakeholder companies
Lajos Sarosi (Chief Executive Officer and Co-founder, HungaroTrial)
Christopher Rupp (Vice President of Global Marketing and Commercial Operations, NAMSA)
Christian Wolflehner (General Manager, CW Research & Management)
Troy Mccall (Chief Operating Officer, CROMSOURCE)
Nazish Urooj (Senior manager, Medical & Clinical Operations, Metrics Research)
C. Omprakash (Technical Director and Partner, Vyomus Consulting)
Tania Persson (Director of Business Development, A+ Science)
Alexa Foltin-Mertgen (Business Development Manager, AtoZ-CRO)

Key companies covered in the report
Avania (formerly known as Factory CRO)
Charles River Laboratories
Clinlogix
CROMSOURCE
CSSi LifeSciences™
Eurofins Medical Device Testing
genae
IMARC Research
IQVIA
Medpace
NAMSA
Qserve Group
Regulatory and Clinical Research Institute (now a part of Covance)
WuXi AppTec

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html

Other Recent Offerings
1. Contract Regulatory Affairs Management Market for Medical Devices, 2019-2030
2. Medical Device Labels Manufacturing Market, 2019 - 2030
3. Medical Device Contract Manufacturing Market, 2019-2030

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.